Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Neuwahl

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
JAMA Surgery|May 30, 2013
The employed surgeon: a changing professional paradigmAnthony G Charles, Shiara Ortiz-Pujols, Thomas Ricketts, et al.
Journal of Managed Care & Specialty Pharmacy|January 27, 2023
Does access to free medication reduce health system costs? An evaluation of the Dispensary of Hope programBenjamin T Allaire, Yan Tang, Simon Neuwahl, et al.
Preventing Chronic Disease|July 29, 2016
Intervention Costs From Communities Putting Prevention to WorkAmanda A Honeycutt, Olga A Khavjou, Christina Bradley, et al.
Preventing Chronic Disease|April 30, 2026
A Model to Assess the Costs and Consequences of Changes in Diet and Nutrition From Potential Population-Wide Policies: The Microsimulation of Nutrition, Diabetes, and Cardiovascular Disease (MONDAC)Benjamin T Allaire, Thomas Hoerger, Rainer Hilscher, et al.
Diabetes Care|July 3, 2025
A New Simulation Model to Estimate the Long-term Health and Cost Outcomes of Interventions for People With Type 1 DiabetesCarolina Barbosa, Thomas J Hoerger, Nicole A Mack, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 26, 2023
A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-EffectivenessThomas J Hoerger, Rainer Hilscher, Simon Neuwahl, et al.
AJPM Focus|October 27, 2025
Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention ProgramWilliam H Herman, Benjamin D Tyndall, O Kenrik Duru, et al.
The Lancet. Global Health|February 16, 2023
Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health ResearchJackie K Patterson, Simon Neuwahl, Norman Goco, et al.
The Lancet. Global Health|March 28, 2025
Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trialJackie K Patterson, Simon Neuwahl, Sydney Kirsch, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
JAMA Surgery|May 30, 2013
The employed surgeon: a changing professional paradigmAnthony G Charles, Shiara Ortiz-Pujols, Thomas Ricketts, et al.
Journal of Managed Care & Specialty Pharmacy|January 27, 2023
Does access to free medication reduce health system costs? An evaluation of the Dispensary of Hope programBenjamin T Allaire, Yan Tang, Simon Neuwahl, et al.
Preventing Chronic Disease|July 29, 2016
Intervention Costs From Communities Putting Prevention to WorkAmanda A Honeycutt, Olga A Khavjou, Christina Bradley, et al.
Preventing Chronic Disease|April 30, 2026
A Model to Assess the Costs and Consequences of Changes in Diet and Nutrition From Potential Population-Wide Policies: The Microsimulation of Nutrition, Diabetes, and Cardiovascular Disease (MONDAC)Benjamin T Allaire, Thomas Hoerger, Rainer Hilscher, et al.
Diabetes Care|July 3, 2025
A New Simulation Model to Estimate the Long-term Health and Cost Outcomes of Interventions for People With Type 1 DiabetesCarolina Barbosa, Thomas J Hoerger, Nicole A Mack, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 26, 2023
A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-EffectivenessThomas J Hoerger, Rainer Hilscher, Simon Neuwahl, et al.
AJPM Focus|October 27, 2025
Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention ProgramWilliam H Herman, Benjamin D Tyndall, O Kenrik Duru, et al.
The Lancet. Global Health|February 16, 2023
Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health ResearchJackie K Patterson, Simon Neuwahl, Norman Goco, et al.
The Lancet. Global Health|March 28, 2025
Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trialJackie K Patterson, Simon Neuwahl, Sydney Kirsch, et al.
Pageof 2